Targeting strategies in cancer gene therapy
1Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, the Chinese Academy of Sciences, Shanghai 200031, China. xyliu@sibs.ac.cn
Abstract:
Targeting to the tumor tissues can improve the therapeutic effect of gene transfer by preventing damage of healthy tissues and decreasing the risk of germ line transduction. Although targeting seems not important for intratumoral gene delivery, it becomes crucial when systemic gene transfer is performed. Targeted gene therapy of malignancies can be achieved through targeted gene delivery or targeted gene transcription. Recent advances in targeted delivery include the successful use of bifunctional crosslinkers to target adenoviral and retroviral vectors, inserting short targeting peptides and larger polypeptide-binding domains into the coat proteins of a number of different viral vectors, and replication-competent vectors which have been shown to be promise as anti-cancer agents. Some other non-viral therapeutic agents, including receptor-mediated DNA or liposome-DNA complex, and bacteria vehicles have also been developed. Some of these delivery systems are currently in clinical trials. For targeted and regulable gene transcription, tissue or tumor specific promoters and some manual regulatory systems are used to regulate therapeutic gene expression. Antisense oligonucleotides, some ribozyme and DNAzyme molecules are developed to inactivate genes that are essential to the development of many tumors.
Insights
Targeted gene therapy improves cancer treatment by directing gene transfer to tumors, minimizing side effects and risks. Advances include novel viral and non-viral delivery systems and gene transcription regulation for enhanced efficacy.
Area of Science:
- Oncology
- Molecular Biology
- Gene Therapy
Background:
- Targeted gene delivery enhances therapeutic efficacy in cancer by minimizing off-target effects and germline transduction.
- Systemic gene transfer necessitates precise targeting strategies for effective cancer treatment.
- Gene therapy for malignancies can be achieved via targeted delivery or transcription control.
Purpose of the Study:
- To review recent advancements in targeted gene delivery and transcription for cancer therapy.
- To highlight novel viral and non-viral delivery systems for targeted gene therapy.
- To discuss strategies for regulating therapeutic gene expression in tumor cells.
Main Methods:
- Utilizing bifunctional crosslinkers for viral vector targeting (adenoviral, retroviral).
- Engineering viral vectors with targeting peptides and polypeptide-binding domains.
- Developing non-viral delivery systems like receptor-mediated DNA/liposome-DNA complexes and bacterial vehicles.
- Employing tumor-specific promoters and regulatory systems for controlled gene transcription.
- Developing antisense oligonucleotides, ribozymes, and DNAzymes for gene inactivation.
Main Results:
- Demonstrated success of engineered viral vectors and non-viral agents in targeted delivery.
- Replication-competent vectors show promise as anti-cancer agents.
- Several targeted delivery systems are progressing through clinical trials.
- Tissue-specific promoters enable targeted gene expression.
- Oligonucleotide-based therapies can inactivate oncogenic genes.
Conclusions:
- Targeted gene therapy offers a promising approach to improve cancer treatment outcomes.
- Ongoing research and clinical trials are advancing the development of effective targeted gene delivery and transcription strategies.
- The combination of targeted delivery and regulated gene expression holds significant potential for future cancer therapeutics.
More Related Videos
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
09:37Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
Related Concept Videos
Gene Therapy
Cancer
Gene Therapy
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
